Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium and Divalproex in Huntington's Disease
NCT00095355Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Oct 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium, divalproex sodium in Huntington's disease (HD), sponsored by National Institute of Neurological Disorders and Stroke. Started Oct 2004; status: completed.
02
Drugs
lithiumdivalproex sodium
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00095355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095355.